Moulay A Alaoui-Jamali (Moulay Alaoui-Jamali)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Molecular cancer therapeutics

Cancer research

Molecular cancer research : MCR

Oncogene

This page only lists publications with an associated author ORCID identifier.

Publications

Qianhui Yi, Weiguo Liu, Jung Hwa Seo, Jie Su, Moulay A Alaoui-Jamali, Jun Luo, Rongtuan Lin, Jian Hui Wu
Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer. Molecular cancer therapeutics 22 (5) (2023)
Qianhui Yi, Weiguo Liu, Jung Hwa Seo, Jie Su, Moulay A Alaoui-Jamali, Jun Luo, Rongtuan Lin, Jian Hui Wu
Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer. Molecular cancer therapeutics 22 (5) (2023)
Krikor Bijian, Dominik Wernic, Anita K Nivedha, Jie Su, Felicia Phei Lin Lim, Caitlin E Miron, Hind Amzil, Nicolas Moitessier, Moulay A Alaoui-Jamali
Novel Aurora A and Protein Kinase C (α, β1, β2, and θ) Multitarget Inhibitors: Impact of Selenium Atoms on the Potency and Selectivity. Journal of medicinal chemistry 65 (4) (2022)
Henry G Yu, Krikor Bijian, Sabrina D da Silva, Jie Su, Gregoire Morand, Alan Spatz, Moulay A Alaoui-Jamali
NEDD9 links anaplastic thyroid cancer stemness to chromosomal instability through integrated centrosome asymmetry and DNA sensing regulation. Oncogene 41 (21) (2022)
Isabelle Sirois, Adriana Aguilar-Mahecha, Josiane Lafleur, Emma Fowler, Viet Vu, Michelle Scriver, Marguerite Buchanan, Catherine Chabot, Aparna Ramanathan, Banujan Balachandran, Stéphanie Légaré, Ewa Przybytkowski, Cathy Lan, Urszula Krzemien, Luca Cavallone, Olga Aleynikova, Cristiano Ferrario, Marie-Christine Guilbert, Naciba Benlimame, Amine Saad, Moulay A Alaoui-Jamali, Horace Uri Saragovi, Sylvia Josephy, Ciara O'Flanagan, Stephen D Hursting, Vincent R Richard, René Peiman Zahedi, Christoph H Borchers, Eric Bareke, Sheida Nabavi, Peter Tonellato, Josée-Anne Roy, André Robidoux, Elizabeth A Marcus, Catalin Mihalcioiu, Jacek Majewski, Mark Basik
A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability. Molecular cancer research : MCR 17 (12) (2019)
Qianyu Guo, Vivian Z Li, Jessica N Nichol, Fan Huang, William Yang, Samuel E J Preston, Zahra Talat, Hanne Lefrère, Henry Yu, Guihua Zhang, Mark Basik, Christophe Gonçalves, Yao Zhan, Dany Plourde, Jie Su, Jose Torres, Maud Marques, Sara Al Habyan, Krikor Bijian, Frédéric Amant, Michael Witcher, Fariba Behbod, Luke McCaffrey, Moulay A Alaoui-Jamali, Nadia V Giannakopoulos, Muriel Brackstone, Lynne-Marie Postovit, Sonia V Del Rincón, Wilson H Miller
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ. Cancer research 79 (7) (2019)
Tatiana Shorstova, Maud Marques, Jie Su, Jake Johnston, Claudia L Kleinman, Nancy Hamel, Sidong Huang, Moulay A Alaoui-Jamali, William D Foulkes, Michael Witcher
SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors. Cancer research 79 (10) (2019)
Sabrina Daniela da Silva, Bin Xu, Mariana Maschietto, Fabio Albuquerque Marchi, Maisa I Alkailani, Krikor Bijian, Dingzhang Xiao, Moulay A Alaoui-Jamali
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis. Molecular cancer therapeutics 18 (1) (2018)

Moulay A Alaoui-Jamali.css-eqlu8i{font-size:small;padding-left:4px;} (Moulay Alaoui-Jamali)

Publication Activity (10 Years)

Top Topics

Top Venues

Moulay A Alaoui-Jamali (Moulay Alaoui-Jamali)